GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
Recombinant Prokaryotic Lectins
RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and selective isolation of glycosylated biomolecules. Applications
News Jan 2017: Silicon Republic - Innovation: GlycoSeLect Listed as One of "10 Marvellous Medtec Start-Ups You Need to Know" More >>
News May 2016: GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma More >>
Job Opportunity At GlycoSeLect: Exciting Opportunity for a New Biochemist/Molecular Biologist at GlycoSeLect UK More >>